Skip to main content

Volume 19 Supplement 1

12th European Headache Federation Congress jointly with 32nd National Congress of the Italian Society for the Study of Headaches

Meeting abstracts

Publication costs for this supplement were funded by the 12th European Headache Federation Congress and the 32nd National Congress of the Italian Society for the Study of Headaches. PM has received grants from Allergan, Novartis and Teva. He received contributions to research from Allergan, Novartis and Teva, and acted on cosultant activities for Allergan. PM is an employee of Springer Nature. RB has received grants from Allergan, Teva, Dr. Reddy and Trigemina. He also acted on consultant activities for Avanir, Biohaven, Allergan, Teva, Alder, Alkermis, ATI, Depomed, Electocore, Neurlief, Pernix, Pervept, Tekeda and Trigemina. FP declares no competing interest.

Florence, Italy28-30 September 2018

Edited by Paolo Martelletti, Rami Burstein and Francesco Pierelli.

Submit manuscript

Official journal of

Annual Journal Metrics

  • 2022 Citation Impact
    7.4 - 2-year Impact Factor
    7.1 - 5-year Impact Factor
    2.002 - SNIP (Source Normalized Impact per Paper)
    1.593 - SJR (SCImago Journal Rank)

    2023 Speed
    3 days submission to first editorial decision for all manuscripts (Median)
    44 days submission to accept (Median)

    2023 Usage
    3,022,321 downloads
    3,296 Altmetric mentions 

  • ISSN: 1129-2377 (electronic)
  • ISSN: 1129-2369 (print)

Related reading

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us